Meta-analysis and Epidemiologic Studies in Drug Development and Postmarketing Surveillance
- 3 March 1999
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 281 (9) , 841-844
- https://doi.org/10.1001/jama.281.9.841
Abstract
The unmatched ability of prospectively designed randomized trials to provide unbiased, definitive evidence about the benefits and risks of treatments in theKeywords
This publication has 1 reference indexed in Scilit:
- Methodologic variation in case-control studies of reserpine and breast cancerJournal of Chronic Diseases, 1979